Our data on Jag1 expression, as an individual binary marker, reflected a favorable prognostic impact of this protein, which may be considered compatible with the proposed tumor-suppressing role of Notch pathway activation in endometrial cancer [33] [11] and the dual role of Notch activation in cancer [34] [6] [8]. This evidence concerns the gene JAG1 and endometrial cancer.